Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Apostolia Maria Tsimberidou, Jamie V. Shaw, Dejan Juric, Claire Verschraegen, Amy M. Weise, John Sarantopoulos, Gilberto Lopes, John Nemunaitis, Monica Mita, Haeseong Park, Barbara Ellers-Lenz, Hui Tian, Wenyuan Xiong, Remigiusz Kaleta, Razelle Kurzrock
Profundice en los temas de investigación de 'Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer'. En conjunto forman una huella única.